Logo image of BGSF

BGSF INC (BGSF) Stock Fundamental Analysis

USA - NYSE:BGSF - US05601C1053 - Common Stock

3.74 USD
-0.05 (-1.32%)
Last: 10/17/2025, 9:46:38 AM
Fundamental Rating

3

BGSF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. While BGSF seems to be doing ok healthwise, there are quite some concerns on its profitability. BGSF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BGSF has reported negative net income.
BGSF had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BGSF reported negative net income in multiple years.
Of the past 5 years BGSF 4 years had a positive operating cash flow.
BGSF Yearly Net Income VS EBIT VS OCF VS FCFBGSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

BGSF has a Return On Assets of -4.17%. This is in the lower half of the industry: BGSF underperforms 71.95% of its industry peers.
Looking at the Return On Equity, with a value of -7.97%, BGSF is doing worse than 65.85% of the companies in the same industry.
Industry RankSector Rank
ROA -4.17%
ROE -7.97%
ROIC N/A
ROA(3y)1.7%
ROA(5y)3.14%
ROE(3y)3.07%
ROE(5y)5.95%
ROIC(3y)N/A
ROIC(5y)N/A
BGSF Yearly ROA, ROE, ROICBGSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

BGSF's Operating Margin has declined in the last couple of years.
BGSF has a Gross Margin of 33.79%. This is comparable to the rest of the industry: BGSF outperforms 47.56% of its industry peers.
BGSF's Gross Margin has been stable in the last couple of years.
BGSF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.79%
OM growth 3Y-44.52%
OM growth 5Y-33.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y1.42%
BGSF Yearly Profit, Operating, Gross MarginsBGSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

BGSF does not have a ROIC to compare to the WACC, probably because it is not profitable.
BGSF has more shares outstanding than it did 1 year ago.
BGSF has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BGSF has an improved debt to assets ratio.
BGSF Yearly Shares OutstandingBGSF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BGSF Yearly Total Debt VS Total AssetsBGSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

BGSF has an Altman-Z score of 2.02. This is not the best score and indicates that BGSF is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.02, BGSF is doing worse than 62.20% of the companies in the same industry.
The Debt to FCF ratio of BGSF is 3.90, which is a good value as it means it would take BGSF, 3.90 years of fcf income to pay off all of its debts.
BGSF's Debt to FCF ratio of 3.90 is in line compared to the rest of the industry. BGSF outperforms 58.54% of its industry peers.
BGSF has a Debt/Equity ratio of 0.55. This is a neutral value indicating BGSF is somewhat dependend on debt financing.
BGSF has a Debt to Equity ratio (0.55) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.9
Altman-Z 2.02
ROIC/WACCN/A
WACC8.46%
BGSF Yearly LT Debt VS Equity VS FCFBGSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.64 indicates that BGSF should not have too much problems paying its short term obligations.
The Current ratio of BGSF (1.64) is better than 64.63% of its industry peers.
BGSF has a Quick Ratio of 1.64. This is a normal value and indicates that BGSF is financially healthy and should not expect problems in meeting its short term obligations.
BGSF's Quick ratio of 1.64 is fine compared to the rest of the industry. BGSF outperforms 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
BGSF Yearly Current Assets VS Current LiabilitesBGSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

2

3. Growth

3.1 Past

BGSF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -252.38%.
BGSF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.36%.
Measured over the past years, BGSF shows a small growth in Revenue. The Revenue has been growing by 4.39% on average per year.
EPS 1Y (TTM)-252.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)-24.36%
Revenue growth 3Y4.47%
Revenue growth 5Y4.39%
Sales Q2Q%-6.4%

3.2 Future

The Earnings Per Share is expected to grow by 26.57% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -41.07% on average over the next years. This is quite bad
EPS Next Y-113.95%
EPS Next 2Y26.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-66.33%
Revenue Next 2Y-41.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BGSF Yearly Revenue VS EstimatesBGSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BGSF Yearly EPS VS EstimatesBGSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BGSF. In the last year negative earnings were reported.
Also next year BGSF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BGSF Price Earnings VS Forward Price EarningsBGSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BGSF indicates a slightly more expensive valuation: BGSF is more expensive than 69.51% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BGSF is valued cheaper than 97.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.5
EV/EBITDA 31.16
BGSF Per share dataBGSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BGSF's earnings are expected to grow with 26.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.57%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 54.64%, BGSF is a good candidate for dividend investing.
In the last 3 months the price of BGSF has falen by -42.14%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
BGSF's Dividend Yield is rather good when compared to the industry average which is at 3.90. BGSF pays more dividend than 100.00% of the companies in the same industry.
BGSF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 54.64%

5.2 History

The dividend of BGSF decreases each year by -31.61%.
BGSF has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-31.61%
Div Incr Years0
Div Non Decr Years0
BGSF Yearly Dividends per shareBGSF Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BGSF pays out 0.02% of its income as dividend. This is a sustainable payout ratio.
DP0.02%
EPS Next 2Y26.57%
EPS Next 3YN/A
BGSF Yearly Income VS Free CF VS DividendBGSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
BGSF Dividend Payout.BGSF Dividend Payout, showing the Payout Ratio.BGSF Dividend Payout.PayoutRetained Earnings

More info and screens

BGSF INC

NYSE:BGSF (10/17/2025, 9:46:38 AM)

3.74

-0.05 (-1.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-07 2025-08-07/dmh
Earnings (Next)11-06 2025-11-06
Inst Owners29.59%
Inst Owner Change0%
Ins Owners3.88%
Ins Owner Change4.08%
Market Cap41.78M
Analysts85.71
Price Target10.71 (186.36%)
Short Float %3.18%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield 54.64%
Yearly Dividend0.15
Dividend Growth(5Y)-31.61%
DP0.02%
Div Incr Years0
Div Non Decr Years0
Ex-Date10-01 2025-10-01 (2)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.83%
Min EPS beat(2)-1.96%
Max EPS beat(2)37.61%
EPS beat(4)1
Avg EPS beat(4)-67.96%
Min EPS beat(4)-162.39%
Max EPS beat(4)37.61%
EPS beat(8)2
Avg EPS beat(8)-64.49%
EPS beat(12)5
Avg EPS beat(12)31.57%
EPS beat(16)9
Avg EPS beat(16)37.58%
Revenue beat(2)1
Avg Revenue beat(2)15.47%
Min Revenue beat(2)-4.99%
Max Revenue beat(2)35.92%
Revenue beat(4)1
Avg Revenue beat(4)4.33%
Min Revenue beat(4)-6.95%
Max Revenue beat(4)35.92%
Revenue beat(8)1
Avg Revenue beat(8)-0.35%
Revenue beat(12)3
Avg Revenue beat(12)0.4%
Revenue beat(16)5
Avg Revenue beat(16)-4.28%
PT rev (1m)0%
PT rev (3m)5%
EPS NQ rev (1m)-261.11%
EPS NQ rev (3m)-314.81%
EPS NY rev (1m)-1175%
EPS NY rev (3m)-1175%
Revenue NQ rev (1m)-23.88%
Revenue NQ rev (3m)-50.72%
Revenue NY rev (1m)-50.32%
Revenue NY rev (3m)-50.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 3.5
P/OCF 3.32
P/B 0.53
P/tB 0.57
EV/EBITDA 31.16
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)1.07
FCFY28.58%
OCF(TTM)1.13
OCFY30.15%
SpS19.9
BVpS7.01
TBVpS6.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.17%
ROE -7.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.79%
FCFM 5.37%
ROA(3y)1.7%
ROA(5y)3.14%
ROE(3y)3.07%
ROE(5y)5.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.81%
ROCE(5y)9.06%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-44.52%
OM growth 5Y-33.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y1.42%
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.9
Debt/EBITDA 16.3
Cap/Depr 14.93%
Cap/Sales 0.29%
Interest Coverage N/A
Cash Conversion 479.95%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 2.02
F-Score3
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)64.81%
Cap/Depr(5y)64.81%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y-113.95%
EPS Next 2Y26.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.36%
Revenue growth 3Y4.47%
Revenue growth 5Y4.39%
Sales Q2Q%-6.4%
Revenue Next Year-66.33%
Revenue Next 2Y-41.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-118.87%
EBIT growth 3Y-42.04%
EBIT growth 5Y-30.19%
EBIT Next Year-507.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y318.98%
FCF growth 3Y87.31%
FCF growth 5Y7.66%
OCF growth 1Y94.05%
OCF growth 3Y54.12%
OCF growth 5Y6.31%